Close Menu

This article has been updated to correct that Hai Kang Life, not PharmaCyte Biotech, received the CE mark for these tests.

NEW YORK – PharmaCyte Biotech announced on Wednesday that Haig Kang Life has received the CE mark for SARS-CoV-2 tests it has licensed from Hai Kang.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.